Skip to main navigation Skip to search Skip to main content

Chronic lymphocytic leukemia immunologic markers and functional properties of the leukemic cells

  • Hendrik J. Der van Reijden
  • , Ruth van der Gaag
  • , Jantina Pinkster
  • , Hans C. Rümke
  • , Mars B. van't Veer
  • , Cornelis J. M. Melief
  • , Albert E. G. Kr. von Demborne*
  • *Corresponding author for this work
  • University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In 230 cases of chronic lymphocytic leukemia (CLL), marker analysis was performed with rosette techniques and a panel of xeno‐antisera. A monoclonal B‐cell proliferation was found in the majority of cases (94%). In most cases, the B‐cells carried IgM, with or without IgD. Cytoplasmic immunoglobulin‐inclusion bodies were seen in 7% of the cases of B‐CLL. The number of patients with non‐B/non‐T‐CLL was small (2%) in this series. In eight patients (4%), a proliferation of T‐cells was established. These patients had a different clinical presentation and marker analysis of the lymphocytes, together with functional studies, showed that this group represented a mixture of different disease processes. Functional analysis of the B‐CLL cells in 19 cases showed a poor or absent mitogen response and in nine cases the absence of the capacity to differentiate in vitro into plasma cells and/or to produce immunoglobulins. Copyright © 1982 American Cancer Society
Original languageEnglish
Pages (from-to)2826-2833
JournalCancer
Volume50
Issue number12
DOIs
Publication statusPublished - 1982
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Chronic lymphocytic leukemia immunologic markers and functional properties of the leukemic cells'. Together they form a unique fingerprint.

Cite this